Pomalidomide Treatment in Relapsed/Refractory Multiple Myeloma Patients—Real-World Data From Hungary

Pomalidomide is a third generation immunomodulatory drug in the treatment of refractory and relapsed multiple myeloma patients. Our aim was to investigate the efficacy and safety of pomalidomide therapy in a real world setting. Eighty-six Hungarian patients were included, 45 of whom received pomalid...

Descripción completa

Detalles Bibliográficos
Autores principales: Lovas, Szilvia, Obajed Al-Ali, Nóra, Varga, Gergely, Szita, Virág, Alizadeh, Hussain, Plander, Márk, Rajnics, Péter, Illés, Árpád, Szemlaky, Zsuzsa, Mikala, Gábor, Váróczy, László
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pathology and Oncology Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573944/
https://www.ncbi.nlm.nih.gov/pubmed/36262875
http://dx.doi.org/10.3389/pore.2022.1610645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573944/
https://www.ncbi.nlm.nih.gov/pubmed/36262875
http://dx.doi.org/10.3389/pore.2022.1610645

Ejemplares similares